# Symvess

NDC: 83564-110
Generic name: ACELLULAR TISSUE ENGINEERED VESSEL
Labeler / Manufacturer: Humacyte Global, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: IMPLANT
Routes: INTRAVASCULAR
Marketing started: 20241219

FDA application: BLA125812

## Active ingredients

- ACELLULAR TISSUE ENGINEERED VESSEL: 420 mm/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83564-110"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83564-110
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15e9e29f-5aa6-4fc6-b0fe-a48cd1473418